Key Insights

Highlights

Treatment Research

1 treatments under study, led by Enbrace Hr Softgel

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04123483Phase 4Withdrawn

EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders

Showing all 1 trials

Research Network

Common Treatments

  • Enbrace Hr Softgel1

Active Sponsors

  • Massachusetts General Hospital1

Top Investigators

Related Conditions

  • Premenstrual Syndrome1
  • Premenstrual Tension1
  • Premenstrual Dysphoric Disorder1

Activity Timeline